Filing Details
- Accession Number:
- 0001840315-24-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-16 18:55:01
- Reporting Period:
- 2024-01-11
- Accepted Time:
- 2024-01-16 18:55:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1314102 | Eyepoint Pharmaceuticals Inc. | EYEP | Laboratory Analytical Instruments (3826) | 262774444 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1840315 | Therapeutics Ocumension | 56F, One Museum Place 669 Xin Zha Road Jing'An District, Shanghai F4 200041 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-11 | 1,910,500 | $19.45 | 100,221 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- T+2 settlement on Jan 16
Billionaire Hedge Funds
